系所成員

經歷 / 榮譽

學術著作

1. Kao CF, Chen HW, Chen HC, Yang JH, Huang MC, Chiu YH, Lin SK, Lee YC, Liu CM, Chuang LC, Chen CH, Wu JY, Lu RB, Kuo PH. (2016) Identification of susceptible loci and enriched pathways for bipolar II disorder using genome-wide association studies. International Journal of Neuropsychopharmacology. (Accepted) [SCI]
2. Chen WY§, Kao CF§, Chen PY, Lin SK, Huang MC. (2016) Orexin-A level in recently abstinent male methamphetamine abusers. Psychiatry Research 239:9-11. (§Co-first author) [SCI]
3. Chen PY, Lu ML, Huang MC, Kao CF, Kuo PH, Chiu CC, Lin SK, Chen CH. (2015) The relationships of obesity-related genetic variants with metabolic profiles and response to metformin in clozapine-treated patients with schizophrenia. Journal of Clinical Psychopharmacology 35(5):574-578. [SCI]
4. Kao CF, Liu JR, Hung H, Kuo PH. (2015) A robust GWSS method to simultaneously detecting rare and common variants for complex disease. PLoS ONE 10(4):e0120873. [SCI]
5. Yeh FC, Kao CF, Kuo PH. (2015) Explore the features of brain-derived neurotrophic factor in mood disorders. PLoS ONE 10(6):e0128605. [SCI]
6. Lai YC, Kao CF, Lu ML, Chen HC, Chen PY, Chen CH, Shen WW, Wu JY, Lu RB, Kuo PH. (2015) Investigation of associations between NR1D1, RORA and RORB genes and bipolar disorder. PLoS ONE 10(3):e0121245. [SCI]
7. Kao CF, Chuang LC, Kuo PH. (2014) Risk and information evaluation of prioritized genes for complex traits: application to bipolar disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165B(7):596-606. [SCI]
8. Huang MC, Schwandt ML, Chester JA, Kirchhoff AM, Kao CF, Liang T, Tapocik JD, Ramchandani VA, George DT, Hodgkinson CA, Goldman D, Heilig M. (2014) FKBP5 moderates alcohol withdrawal severity: human genetic association and functional validation in knockout mice. Neuropsychopharmacology 39(8):2029-2038. [SCI]
9. Huang MC§, Kao CF§, Chen PY, Lu ML, Kuo PH, Chiu CC, Chen CH. (2014) The genetic association of FTO with metabolic traits in patients with schizophrenia may be modified by antipsychotics. Journal of Clinical Psychopharmacology 34(1):162-165. (§Co-first author) [SCI]
10. Chen YC§, Kao CF§, Lu MK, Yang YK, Jang FL, Liao SC, Chen WJ, Lu RB, Kuo PH. (2014) The relationship of family characteristics and bipolar disorder using causal-pie models. European Psychiatry 29(1):36-43. (§Co-first author) [SCI, SSCI]
11. Chen CH, Huang MC, Kao CF, Lin SK, Kuo PH, Chiu CC, Lu ML. (2013) Effects of adjunctive metformin on metabolic traits in non-diabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: A 24-week, randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry 74(5):e424-430. [SCI, SSCI]
12. Chuang LC, Kao CF, Shih WL, Kuo PH. (2013) Pathway analysis using information from allele-specific gene methylation in genome-wide association studies for bipolar disorder. PLoS ONE 8(1):e53092. [SCI]
13. Shih WL, Kao CF, Chuang LC, Kuo PH. (2012) Incorporating information of microRNAs into pathway analysis in a genome-wide association study of bipolar disorder. Frontiers in Genetics 3:293.
14. Kao CF, Jia P, Zhao Z, Kuo PH. (2012) Enriched pathways for major depressive disorder identified from a genome-wide association study. International Journal of Neuropsychopharmacology 15(10):1401-1411. [SCI]
15. Kuo PH, Kao CF, Chen PY, Chen CH, Tsai YS, Lu ML, Huang MC. (2011) Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients. Journal of Clinical Psychopharmacology 31(6):705-711. [SCI]
16. Jia P§, Kao CF§. Kuo PH, Zhao Z. (2011) A comprehensive network and pathway analysis of candidate genes in major depressive disorder. BMC Systems Biology 5(Suppl 3):S12. (§Co-first author) [SCI]
17. Kao CF, Fang YS, Zhao Z, Kuo PH. (2011) Prioritization and evaluation of depression candidate genes by combining multidimensional data resources. PLoS ONE 6(4):e18696. [SCI]
18. Chen CH, Lu ML, Kuo PH, Tsai CJ, Chen PY, Chiu CC, Kao CF, Huang MC. (2011) Gender differences in the effects of peroxisome proliferator-activated receptor gamma 2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 35(1):239-245. [SCI]

研究室人員